Marksans Pharma recommends 80% final dividend

Marksans Pharma's board has recommended a final dividend of 80 paise per equity share of face value 1 rupee each for the financial year ended March 31, 2025.

The company fixed August 1, 2025, as the record date for determining dividend eligibility. If approved at the annual general meeting on August 8, the dividend will be paid on or after August 21, 2025.